# American Healthcare (AHR) — Earnings

AHR · NYSE · Stock

Canonical page: https://www.lighthorse.io/tickers/ahr/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2026 |
| Period end | Jun 30, 2026 |
| EPS actual | $0.16 |
| EPS estimate | $0.14 |
| EPS surprise | +16.62% |
| Revenue surprise | +3.98% |
| Revenue | $671.0M |
| Revenue estimate | $645.3M |
| Reported | Aug 6, 2026 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1632970/000119312526340269/ahr-20260630.htm) |
| Earnings call | [Transcript](http://o.thsi.cn/dc-d-stock-america.teleconference/162ee56b-0af2-cecd-b854-e24e837d4c1a.html) |

American Healthcare reported Q2 2026 results on August 6, 2026. Earnings per share were $0.16, beating the $0.14 estimate by 16.62%. Revenue was $671.0 million, above the $645.3 million consensus and the highest in the table. Compared with Q2 2025, EPS rose from $0.06 and revenue grew about 24% from $542.5 million.

The record is fairly short, 11 quarters from Q4 2023, and earnings have been uneven. The company posted losses in five of those quarters, most recently in Q1 2025. Full-year EPS moved from a loss of $0.27 in 2024 to a profit of $0.41 in 2025. Since Q2 2025, quarterly EPS has ranged from $0.06 to a table high of $0.33 in Q3 2025. Revenue has risen more steadily, from about $2.07 billion in 2024 to about $2.26 billion in 2025, and first-half 2026 revenue was about 22% above the first half of 2025. Against EPS estimates, the company beat three times, missed seven times and matched once.

Past Q3 reports came on November 12, 2024 and November 6, 2025, pointing to early or mid-November 2026. The next report will show whether EPS holds near the $0.13 to $0.16 range of the first half of 2026.

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2026 | Aug 6, 2026 | $0.14 | $0.16 | 16.62% | $645.3M | $671.0M |
| Q1 2026 | May 7, 2026 | $0.16 | $0.13 | -19.20% | $667.6M | $650.8M |
| Q4 2025 | Feb 26, 2026 | $0.15 | $0.06 | -61.27% | $609.5M | $604.1M |
| Q3 2025 | Nov 6, 2025 | $0.16 | $0.33 | 110.59% | $552.5M | $571.1M |
| Q2 2025 | Aug 7, 2025 | $0.12 | $0.06 | -50.00% | $541.9M | $542.5M |
| Q1 2025 | May 8, 2025 | $0.05 | −$0.04 | -180.00% | $537.4M | $540.6M |
| Q4 2024 | Feb 27, 2025 | $0.08 | −$0.21 | -352.10% | $541.0M | $542.7M |
| Q3 2024 | Nov 12, 2024 | −$0.01 | −$0.03 | -347.76% | $474.3M | $523.8M |
| Q2 2024 | Aug 5, 2024 | $0.00 | $0.01 | 0.00% | $506.6M | $504.6M |
| Q1 2024 | May 13, 2024 | −$0.35 | −$0.04 | 88.68% | $491.8M | $499.5M |
| Q4 2023 | Mar 21, 2024 | −$0.31 | −$0.42 | -34.06% | $471.4M | $482.6M |

## Frequently Asked Questions

### When did American Healthcare (AHR) last report earnings?

American Healthcare last reported on Aug 6, 2026, covering fiscal Q2 2026.

### Did AHR beat earnings estimates?

Yes. American Healthcare reported EPS of $0.16 for Q2 2026 against a $0.14 estimate — a 16.62% beat.

### How much revenue did AHR report last quarter?

American Healthcare reported $671.0M in revenue for Q2 2026, against a consensus estimate of $645.3M.

## Similar Stocks

- [WELL](https://www.lighthorse.io/tickers/well) — Welltower Inc. Common Stock
- [CTRE](https://www.lighthorse.io/tickers/ctre) — CareTrust REIT, Inc. Common Stock
- [VTR](https://www.lighthorse.io/tickers/vtr) — Ventas, Inc. Common Stock

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).